Navigation Links
Oncothyreon to present at the Rodman & Renshaw Annual Global Investment Conference
Date:5/12/2010

SEATTLE, May 12 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Rodman & Renshaw Annual Global Investment Conference taking place in London on May 16-18, 2010.

Dr. Kirkman will present at 10:15 a.m. British Summer Time (5:15 a.m. Eastern Daylight Time) on Tuesday, May 18 at the Grosvenor House Hotel. A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.


'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Oncothyreon reports full year and fourth quarter 2009 financial results
2. Oncothyreon reports first quarter 2010 financial results
3. Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
4. Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement
5. Oncothyreons PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover
6. Oncothyreon reports third quarter 2009 financial results & provides product pipeline update
7. Oncothyreon announces webcast of third quarter 2009 financial results conference call
8. Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
9. Oncothyreon to present at Rodman Renshaw Global Healthcare Conference
10. Oncothyreon reports second quarter 2009 financial results
11. Oncothyreon announces closing of $15.0 million registered direct financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine and Professor ... Einstein College of Medicine and Associate Chairman of the ... He is also Associate Director for Clinical Research at ... Cancer Working Group, a multidisciplinary group of physicians and ... serves as Vice Chair of the National Cancer Institute ...
(Date:5/17/2013)... rejection occurs when the transplant recipient,s immune system identifies ... It was previously thought that T cells, the immune ... molecules known as chemokines in order to migrate to ... Journal of Clinical Investigation , Fadi Lakkis and colleagues ... that chemokine stimulation of T cells is not required ...
(Date:5/17/2013)... provider of scientific, technical and medical information products and ... in Reproductive BioMedicine Online on ... abnormal chromosomal composition can be identified by the rate ... the risk of genetic abnormality without a biopsy. In ... retrospective study, using their predictive model to assess the ...
(Date:5/17/2013)... May 17, 2013 •    First of its ... for sustainability ,     New facility will help solve ... , Syngenta unveiled its new crop research ... company’s RTP Innovation Center. The first of its kind, ... simulate any agricultural climate and precisely measure plant inputs ...
Breaking Biology Technology:Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3
... 13 On February 10, 2009, NeoStem, Inc. (NYSE ... NYSE Alternext US (the "Alternext") indicating that the Company ... Alternext Company Guide (the "Guide"), which requires a listed ... November 3, 2008, the Company had announced that it ...
... Quarter,TORONTO, Feb. 13 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. ... for the biopharmaceutical industry, it has maintained its ... goal of sustained profitability. The Company was announcing ... 2008. , In a news release today, William ...
... -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" ... high-quality, pharmaceutical grade,glucose products in China, today reported ... ended December 31, 2008. , ... the second quarter,compared with the September quarter," said ...
Cached Biology Technology:NeoStem Receives Notice of Noncompliance from NYSE Alternext US 2Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 2Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 3Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 4Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 2Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 3Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 4Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 5Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 6Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 7Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 8Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 9Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 10Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results 11
(Date:5/17/2013)... MD The Federation of American Societies for Experimental ... National Institutes of Health (NIH) funding trends highlighting the ... support critical research. The FASEB analysis follows a May ... Collins, MD, PhD, who testified that the $1.6 billion ... sequestration is "having a substantial impact on the scientific ...
(Date:5/16/2013)... MARC (Maximizing Access to Research Careers) Program has ... for Developmental Biology (SDB) 72nd Annual Meeting in ... are meant to promote the entry of students, ... mainstream of the basic science community and to ... SDB 2013 Annual Meeting. , Awards are given ...
(Date:5/16/2013)... Injectable nanoparticles developed at MIT may someday eliminate ... to constantly monitor their blood-sugar levels and inject ... to sense glucose levels in the body and ... thereby replacing the function of pancreatic islet cells, ... diabetes. Ultimately, this type of system could ensure ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
... -- Investigators at Georgia State University,s Neuroscience Institute ... to identify the most likely reason analgesic drug ... males. This discovery is a major step toward ... persistent pain. "Opioid-based narcotics (such as morphine) ...
... challenges current ideas about the insect brain, researchers have found ... foraging honey bees alert their comrades to potential food sources ... only when the hive is in need. They do this ... on a specialized "dance floor" in the hive. The dance ...
... grand Redwood trees to the common Snowdrop. Although we cannot ... network of roots. What determines the pattern of root growth ... week in PLoS Biology shows that the shape ... from it because shape determines hormone concentration. The work ...
Cached Biology News:Study first to pinpoint why analgesic drugs may be less potent in females than in males 2Honey bees on cocaine dance more, changing ideas about the insect brain 2Honey bees on cocaine dance more, changing ideas about the insect brain 3
Request Info...
Assay Kit formatted for flow cytometric detection of levels of phosphorylated histone H2A.X....
Request Info...
... system. For real-time or pre-programmed liquid ... or general liquid-handling research applications. >UL> ... Run experiments automatically - even ... flexibility Turnkey perfusion system includes ...
Biology Products: